Market Cap 3.64B
Revenue (ttm) 290.52M
Net Income (ttm) 89.16M
EPS (ttm) N/A
PE Ratio 27.98
Forward PE 22.05
Profit Margin 30.69%
Debt to Equity Ratio 0.00
Volume 380,400
Avg Vol 355,632
Day's Range N/A - N/A
Shares Out 28.90M
Stochastic %K 29%
Beta 0.79
Analysts Strong Sell
Price Target $206.90

Latest News on KRYS

Krystal Biotech, Inc. (KRYS) Q1 2025 Earnings Call Transcript

May 6, 2025, 2:43 PM EDT - 26 days ago

Krystal Biotech, Inc. (KRYS) Q1 2025 Earnings Call Transcript


Krystal Biotech to Present at Upcoming Scientific Conferences

Apr 24, 2025, 8:00 AM EDT - 5 weeks ago

Krystal Biotech to Present at Upcoming Scientific Conferences


Krystal Biotech, Inc. (KRYS) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 11:43 AM EST - 3 months ago

Krystal Biotech, Inc. (KRYS) Q4 2024 Earnings Call Transcript


Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy

Dec 27, 2024, 8:30 AM EST - 5 months ago

Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy


Krystal Biotech to Present at Upcoming Investor Conferences

Nov 27, 2024, 7:00 AM EST - 6 months ago

Krystal Biotech to Present at Upcoming Investor Conferences


Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 3:31 PM EST - 7 months ago

Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call Transcript


Krystal Biotech, Inc. (KRYS) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 8:10 PM EDT - 10 months ago

Krystal Biotech, Inc. (KRYS) Q2 2024 Earnings Call Transcript


Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript

May 6, 2024, 11:44 AM EDT - 1 year ago

Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript


Krystal Biotech, Inc. (KRYS) Q4 2023 Earnings Call Transcript

Feb 26, 2024, 11:47 AM EST - 1 year ago

Krystal Biotech, Inc. (KRYS) Q4 2023 Earnings Call Transcript


Krystal Biotech Inc. (KRYS) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 11:43 AM EST - 1 year ago

Krystal Biotech Inc. (KRYS) Q3 2023 Earnings Call Transcript